Fresenius SE & Co. (OTCMKTS:FSNUY) Short Interest Up 625.2% in February

Fresenius SE & Co. (OTCMKTS:FSNUY) was the target of a significant increase in short interest in February. As of February 27th, there was short interest totaling 65,445 shares, an increase of 625.2% from the February 12th total of 9,025 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average daily trading volume, of 79,373 shares, the days-to-cover ratio is currently 0.8 days. Based on an average daily trading volume, of 79,373 shares, the days-to-cover ratio is currently 0.8 days. Approximately 0.0% of the company’s stock are sold short.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on FSNUY shares. Citigroup restated a “buy” rating on shares of Fresenius SE & Co. in a research note on Tuesday, February 3rd. Morgan Stanley reiterated an “overweight” rating on shares of Fresenius SE & Co. in a report on Monday, December 15th. Three analysts have rated the stock with a Buy rating, According to MarketBeat, the company presently has an average rating of “Buy”.

Fresenius SE & Co. Stock Up 0.4%

Shares of Fresenius SE & Co. stock traded up $0.05 during trading hours on Tuesday, reaching $14.02. 112,026 shares of the company’s stock were exchanged, compared to its average volume of 67,351. The company has a 50 day moving average of $14.56 and a two-hundred day moving average of $14.45. Fresenius SE & Co. has a fifty-two week low of $9.78 and a fifty-two week high of $33.93. The company has a current ratio of 1.26, a quick ratio of 0.99 and a debt-to-equity ratio of 0.49. The stock has a market cap of $31.59 billion, a P/E ratio of 22.25 and a beta of 0.75.

Fresenius SE & Co. (OTCMKTS:FSNUY) last released its earnings results on Wednesday, February 25th. The company reported $0.28 earnings per share (EPS) for the quarter. The business had revenue of $6.94 billion for the quarter. Fresenius SE & Co. had a return on equity of 10.38% and a net margin of 5.71%. On average, sell-side analysts forecast that Fresenius SE & Co. will post 0.79 EPS for the current fiscal year.

About Fresenius SE & Co.

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.